相关实验视频
Updated: Jun 28, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.1K
与ixekizumab相关的广泛性结肠炎
María Luisa López García1, María Paz Arreba González2, Leire Irusta Olano2
1Aparato Digestivo, Hospital Universitario Basurto, España.
Revista espanola de enfermedades digestivas
|April 18, 2024
概括
一名患者在为结性脊柱炎治疗ixekizumab治疗3个月后出现了大肠炎. 这一案例突出显示了交白素-17 (IL-17) 抑制剂的潜在不良影响.
科学领域:
- 胃肠病学 胃肠病学
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
背景情况:
- 结性脊柱炎是一种炎症状况,通常用生物疗法治疗.
- 干白素-17 (IL-17) 抑制剂越来越多地用于脊椎关节炎和其他炎症性疾病.
- 胃肠道副作用,包括大肠炎,是生物药物的潜在问题.
研究的目的:
- 报告一例临床广泛结肠炎病例.
- 为了调查Ixekizumab (一种IL-17抑制剂) 与结肠炎的发展之间的潜在关联.
- 提高临床医生对这种罕见不良事件的认识.
主要方法:
- 一个56岁的女性患有结性脊柱炎的病例报告.
- 临床表现:发烧,左下腔疼痛和腹.
- 诊断工作包括腹腔皮层计算机断层扫描和结肠镜检查.
主要成果:
- 计算机断层扫描显示了胰腺炎.
- 结肠镜检查显示,结肠附近持续存在深层和粘膜脆性.
- 经过全面评估,诊断出与IL-17抑制剂治疗相关的广泛结肠炎.
结论:
- 伊克西祖马布治疗与这位患者的广泛性结肠炎的发展有关.
- 这一案例强调了在接受IL-17抑制剂的患者中监测胃肠道不良事件的重要性.
- 可能需要进一步的研究来阐明与IL-17抑制相关的结肠炎的机制和发病率.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
173
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
173
Inflammatory Bowel Disease II: Crohn's Disease
227
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
227
Chronic Bowel Disorders: Introduction
449
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
449
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
161
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
161

